Variant report
Variant | nsv520085 |
---|---|
Chromosome Location | chr8:87034234-87041874 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:87035112..87036851-chr8:87038514..87041936,4 | K562 | blood: | |
2 | chr8:87035737..87039088-chr8:87040580..87043413,3 | MCF-7 | breast: | |
3 | chr8:87035112..87036851-chr8:87038514..87041936,4 | K562 | blood: | |
4 | chr8:87035737..87039088-chr8:87040580..87043413,3 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs11994068 | chr8:87034234-87034235 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs140815213 | chr8:87034235-87034236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11994076 | chr8:87034267-87034268 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs150144740 | chr8:87034294-87034295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562061222 | chr8:87034337-87034338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs116633062 | chr8:87034356-87034357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375004660 | chr8:87034400-87034401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138422319 | chr8:87034430-87034431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141233374 | chr8:87034460-87034461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533097347 | chr8:87034623-87034624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372555691 | chr8:87034637-87034638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1483767 | chr8:87034725-87034726 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs528944253 | chr8:87034728-87034729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1351776 | chr8:87034770-87034771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371001014 | chr8:87034804-87034805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs548714079 | chr8:87034835-87034836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565323307 | chr8:87034843-87034844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534578691 | chr8:87034869-87034870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35536711 | chr8:87034962-87034963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs397696587 | chr8:87034966-87034967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563668442 | chr8:87035003-87035004 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551114501 | chr8:87035086-87035087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571081727 | chr8:87035136-87035137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75353466 | chr8:87035146-87035147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556787371 | chr8:87035175-87035176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536787539 | chr8:87035176-87035177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7846370 | chr8:87035290-87035291 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs182788329 | chr8:87035294-87035295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373139908 | chr8:87035296-87035297 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75833107 | chr8:87035329-87035330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs541386814 | chr8:87035341-87035342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564326759 | chr8:87035361-87035362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs115821419 | chr8:87035368-87035369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543350412 | chr8:87035376-87035377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs114080250 | chr8:87035418-87035419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11995120 | chr8:87035460-87035461 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs548784086 | chr8:87035476-87035477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558998186 | chr8:87035496-87035497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528180163 | chr8:87035511-87035512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551319403 | chr8:87035527-87035528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs137942916 | chr8:87035603-87035604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540124603 | chr8:87035613-87035614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550525283 | chr8:87035650-87035651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200099685 | chr8:87035662-87035663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536020663 | chr8:87035674-87035675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs556016385 | chr8:87035706-87035707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575800476 | chr8:87035749-87035750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117498476 | chr8:87035757-87035758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558122867 | chr8:87035794-87035795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79765216 | chr8:87035795-87035796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Autism | 20841430 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
head and neck squamous cell carcinoma | 19451471 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:87033000-87035000 | Weak transcription | Ovary | ovary |
2 | chr8:87033600-87045800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr8:87034000-87048000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr8:87034200-87035400 | Enhancers | Brain Hippocampus Middle | brain |
5 | chr8:87034600-87035400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:87034600-87035400 | Enhancers | Brain Anterior Caudate | brain |
7 | chr8:87035000-87035200 | Enhancers | Ovary | ovary |
8 | chr8:87036000-87037200 | Enhancers | Placenta | Placenta |
9 | chr8:87036800-87037400 | Enhancers | Adipose Nuclei | Adipose |
10 | chr8:87036800-87038000 | Enhancers | Liver | Liver |
11 | chr8:87038200-87038800 | Enhancers | Fetal Stomach | stomach |
12 | chr8:87040400-87041000 | Enhancers | Primary neutrophils fromperipheralblood | blood |